The following is a summary of “Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid ...

( MENAFN - JCN NewsWire) FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the treatment of Early Alzheimer's disease LEQEMBI is the only ...

A new study reveals that common cardiovascular conditions like high blood pressure and diabetes, known to damage brain blood ...

In patients with transthyretin amyloid cardiomyopathy, the high-affinity TTR stabilizer, acoramidis, is associated with better clinical outcomes compared with placebo. Acoramidis is associated with ...

It’s been over a year since SAG and the WGA ended their months-long strikes with agreements that sought to address the coming impact of artificial intelligence on film and TV production.

Abbreviations: AS = arteriosclerosis; CAA = cerebral amyloid angiopathy; CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; FMD = fibromuscular ...

in the walls of cerebral blood vessels as cerebral amyloid angiopathy (CAA), leading to vascular injury and extravasation of fluid (ARIA in the form of vasogenic edema) or red blood cells (ARIA in the ...

Background: Sporadic cerebral small-vessel disease (CSVD), i.e., hypertensive arteriopathy (HA) and cerebral amyloid angiopathy (CAA), is the main cause of spontaneous intracerebral hemorrhage (ICH).

Two main forms of sporadic SVD have been described: arteriolosclerosis and cerebral amyloid angiopathy (CAA). The former describes a group of small vessel pathological processes. Arteriolosclerosis ...